METABolic Deterioration in HTX Determines Outcomes
Recruiting · NCT07372820 · Observational (researchers observe without assigning treatment) · Lead sponsor: Heinrich-Heine University, Duesseldorf
View the official record on ClinicalTrials.gov →What this trial is about
METAB-HTX is a prospective, longitudinal cohort study evaluating cardiac and systemic metabolism in heart transplant recipients.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age: ≥ 18 years
- Planned or already conducted heart transplantation
- Informed consent
Exclusion criteria
- Absence of informed consent
Where it is running
1 location listed.
- University-Hospital Düsseldorf Division of Cardiology, Pneumology and Angiology - Düsseldorf, North Rhine-Westphalia, Germany